People with high cholesterol end up paying significantly higher travel insurance premiums even though the price increase is not justified by the cost of insuring them, an investigation by The Times has found.
In many cases, insurers quote twice the cost for insurance to the millions of Britons with raised cholesterol, even if it is controlled with statins — a figure that experts said was totally out of proportion to the actual increased risk. The rise was also out of line with life and health insurance, where people taking statins do not generally pay more.
Jules Payne, chief executive of Heart UK, said that this policy effectively penalised those who had been responsible enough to get their cholesterol checked and were working to control it. “There is no reason why insurance premiums should be higher because of raised cholesterol that is being managed,” she said. “This penalises responsible people who are actually at lower risk than many others.”